156 related articles for article (PubMed ID: 10685875)
1. A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo.
Rowley HL; Needham PL; Kilpatrick IC; Heal DJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):187-92. PubMed ID: 10685875
[TBL] [Abstract][Full Text] [Related]
2. Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving rats.
Rowley HL; Kilpatrick IC; Needham PL; Heal DJ
Neuropharmacology; 1998 Jul; 37(7):937-44. PubMed ID: 9776389
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
Li XM; Perry KW; Wong DT; Bymaster FP
Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
[TBL] [Abstract][Full Text] [Related]
6. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
[TBL] [Abstract][Full Text] [Related]
8. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile.
Needham PL; Atkinson J; Skill MJ; Heal DJ
Psychopharmacol Bull; 1996; 32(1):123-8. PubMed ID: 8927661
[TBL] [Abstract][Full Text] [Related]
9. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
Li Z; Prus AJ; Dai J; Meltzer HY
J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
[TBL] [Abstract][Full Text] [Related]
11. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
[TBL] [Abstract][Full Text] [Related]
12. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Jardemark KE; Liang X; Arvanov V; Wang RY
Neuroscience; 2000; 100(1):1-9. PubMed ID: 10996453
[TBL] [Abstract][Full Text] [Related]
13. Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.
Yamamura S; Ohoyama K; Hamaguchi T; Nakagawa M; Suzuki D; Matsumoto T; Motomura E; Tanii H; Shiroyama T; Okada M
Br J Pharmacol; 2009 Jun; 157(4):656-65. PubMed ID: 19371334
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors.
Czyrak A; Jaros T; Moryl E; Maj J
Pharmacopsychiatry; 1993 Mar; 26(2):53-8. PubMed ID: 7690975
[TBL] [Abstract][Full Text] [Related]
15. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
17. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
Nakamura S; Ago Y; Itoh S; Koyama Y; Baba A; Matsuda T
Eur J Pharmacol; 2005 Dec; 528(1-3):95-8. PubMed ID: 16321379
[TBL] [Abstract][Full Text] [Related]
18. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Reuss B; Unsicker K
Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
[TBL] [Abstract][Full Text] [Related]
19. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
Toua C; Brand L; Möller M; Emsley RA; Harvey BH
Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
[TBL] [Abstract][Full Text] [Related]
20. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
